Andelyn Biosciences

Andelyn Biosciences is a biopharmaceutical CDMO Pioneering Solutions That Turn Hope into Reality™

[Alliance for Regenerative Medicine (ARM) @alliancerm]

4/8 @Battelle, @Amplify_Bio, and @AndelynBio win $149m contract from National Institute of Neurological Disorders to develop advanced therapies to treat neurological conditions.
https://t.co/l37pYmRjAI

[Andelyn Biosciences @AndelynBio]

Team Andelyn is down at @Phacilitate Miami! Come see us at booth #311! #AndelynBio #AndelynBiosciences #Phacilitate #advancedtherapies #celltherapy #genetherapy #cellandgenetherapy #powerofpartnerships #advancedtherapiesweek

[Andelyn Biosciences @AndelynBio]

With 20+ years of experience manufacturing viral vectors, Andelyn’s scientific expertise for development and characterization has led to GMP material being produced for over 75+ worldwide clinical trials and 400+ cGMP clinical batches.
https://t.co/SlLI2UP6qg

[Andelyn Biosciences @AndelynBio]

View Andelyn Biosciences special edition feature in BIOPROCESS ONLINE. Facilitate and Implement Rapid Process Changes In Gene Therapy Manufacturing!

https://t.co/886slz704J

[Andelyn Biosciences @AndelynBio]

The Andelyn Development is the home of Andelyn’s research, process development, and analytical development, expanding Andelyn’s capabilities and meeting client demand!

https://t.co/qGxMFnLq1k

[Andelyn Biosciences @AndelynBio]

**Event Alert**

Andelyn Biosciences will be attending Advanced Therapies Week from January 17-20, 2023, at the Miami Beach Convention Center!

Follow us on Twitter to keep up to date about this upcoming event!

https://t.co/5Aw9SiKDOU

[Andelyn Biosciences @AndelynBio]

An interesting article about 4D Molecular Therapeutics. They are developing gene therapies for ophthalmology, cardiology, and pulmonology using a novel AAV vector platform.

https://t.co/basgCltWNg

#genetherapy #andelyn #aav

[Andelyn Biosciences @AndelynBio]

Andelyn Biosciences deep expertise in both innovation and tech transfers allows for tremendous flexibility for adherent and suspension based manufacturing at scales from 1L to 2000L.

https://t.co/bBH4ynnKTa

[Andelyn Biosciences @AndelynBio]

Opus has acquired two new AAV-based gene therapy candidates for inherited retinal disease. 2023 should be an exciting year for gene therapies for retinal diseases!

https://t.co/c5yt5FrKPM

#genetherapy #andelyn

[Andelyn Biosciences @AndelynBio]

Andelyn Biosciences utilizes the latest manufacturing optimization tools to maximize efficiencies and accelerate timelines.

Speak with an expert or learn more: https://t.co/uvajhYVDFk

#GeneTherapy #CDMO #genetherapymanufacturing #clinic #andelyn #viralvectormanufacturing

[Andelyn Biosciences @AndelynBio]

Nice to see gene therapies on a list of FDA-approved drugs in 2022. Three that were approved this year treat rare diseases bringing the total to five!

We can’t wait to usher in more gene therapy treatments.
#genetherapy #andelyn

https://t.co/Bxpa89n3CP

[Andelyn Biosciences @AndelynBio]

Gene editing treatments are looking promising for the treatment of some forms of ALS. A CRISPR/Cas9 system delivered by AAVs was used to remove the repeat expansion C9ORF72 gene (the most common genetic cause of ALS) in both mice and human cells.

https://t.co/Vaj89W8XFL

[Andelyn Biosciences @AndelynBio]

Experts from Andelyn Biosciences give their perspectives on challenges and opportunities in the industry.
https://t.co/BTq6Uq0qfT

[Andelyn Biosciences @AndelynBio]

**Event Alert**

Andelyn Biosciences will be attending Advanced Therapies Week from January 17-20, 2023, at the Miami Beach Convention Center!

Follow our LinkedIn page to keep up to date about this upcoming event!

https://t.co/eiLCK2rWbH

[Andelyn Biosciences @AndelynBio]

A new marketing report estimates that the gene therapy market will surpass $3.25 Billion (USD) by 2030 with a CAGR of 19.1%!

https://t.co/7hP5rEypF2

#genetherapy #andelyn

[Andelyn Biosciences @AndelynBio]

UMass Chan Medical School has established the Translational Institute for Molecular Therapeutics to advance gene therapy development. Current clinical trials include therapeutics for Tay-Sachs disease and amyotrophic lateral sclerosis (ALS).

https://t.co/sOpLSZHJOg

[Andelyn Biosciences @AndelynBio]

Andelyn Biosciences is the pioneer in cell and gene therapy.
Here are a few reasons why Andelyn is your trusted expert!

Learn more:
https://t.co/qJg4sQzNdM

[Andelyn Biosciences @AndelynBio]

Exciting news for the treatment of hemophilia B. Pfizer has announced positive results from their phase 3 study of Fidanacogene elaparvovec, an investigational AAV vector containing a high-activity human coagulation FIX gene.

https://t.co/dL7COHKymZ

#aav #genetherapy #andelyn

[Andelyn Biosciences @AndelynBio]

The new Andelyn Corporate Center (ACC) has 14 upstream rooms and the downstream and support rooms to meet the demanding needs of the gene therapy community.

https://t.co/fxyFnUT14y

This is just a part of what makes Andelyn your trusted team in Gene Therapy manufacturing.

[Andelyn Biosciences @AndelynBio]

An interesting summary of two FDA-cleared gene therapies for b-thalessemia and Cerebral adrenoleukodystrophy (CALD).

https://t.co/569XeTgtKM

#genetherapy #andelyn